Brief: Synthaverse Signs Deal With Biodrug For Min. Eur 5.6 Mln P.A.
Dec 10 (Reuters) - Synthaverse SA SVEP.WA :
* SIGNS DEAL WITH BIODRUG FOR ONKO BCG 100
* BIODRUG GRANTED LICENSE TO REGISTER AND DISTRIBUTE ONKO IN
FOUR
COUNTRIES
* MINIMUM ORDER VALUE FOR FIRST 5 YEARS SET AT €5.55 MLN
* ANNUAL ORDER FORECAST FOR ONKO SET FOR 5 YEARS
Source text: urn:newsml:reuters.com:*:nEMbgjpMha
Further company coverage: SVEP.WA
(Reporting by Gdańsk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility